Neurocrine Biosciences (NBIX)

• Market cap: $13.6B
• 1 day: -1.38%
• 5 days: 1.27%
• 1 month: -3.47%
• 3 months: -1.43%
• 6 months: -0.51%
• Year to date: -3.23%
• 1 year: -11.24%
• 5 years: 28.33%
• 10 years: 217.23%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.

Employees: 1,800